12:00 AM
 | 
Oct 04, 1999
 |  BC Week In Review  |  Company News  |  Other News

Epitope other research news

EPTO received a $1.1 million Phase I/II SBIR grant from the National Institute of Allergy and Infectious...

Read the full 64 word article

User Sign in

Trial Subscription

Get a 4-week free trial subscription to BioCentury Week In Review

Article Purchase

$35 USD
More Info >